Open
Genomic Applications Partnership Program (GAPP)
Genomic Applications Partnership Program funds genomics-derived R&D projects
Last Update: May 1, 2026
Funding available
$ 100,000 - $ 6,000,000
Timeline
- Open Date : February 3, 2026
Location
Ontario, Canada
Overview
The Genomic Applications Partnership Program (GAPP) by Genome Canada provides funding up to $6 million for downstream R&D projects that apply genomics-derived or enabling technologies to real-world challenges identified by Receptor organizations, with a focus on late-stage R&D for near-term commercialization or implementation. Eligible activities must involve active collaboration between an academic researcher and a Receptor organization to generate significant socio-economic benefits in Canada.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Increase performance through digital transformation
- Develop strategic partnerships
- Develop a new product or service
Eligible Funding
- Maximum amount : 6,000,000 $
- Minimum amount : 100,000 $
- Up to 1% of project cost
Timeline
- Open Date : February 3, 2026
Eligible candidates
Eligible Industries
- Agriculture, forestry, fishing and hunting
- Professional, scientific and technical services
- Health care and social assistance
- Public administration
Location
- Ontario
Legal structures
- Non-profit
- Public or Parapublic institution
- For-profit business
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Canadians
- Startups
Non-profit candidates
Sector of operation
- Higher Education
- Research
- Hospitals and Rehabilitation
- Other Health Services
- Environment
- Economic, Social and Community Development
- Business Associations
Target groups
- General public
- Business owners / entrepreneurs
- Nonprofits / charities
- Academia / students
Revenue structures
- All structures
Scope
- National
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Development and application of genomics-derived or genomics-enabling tools, products, or processes
- Late-stage R&D projects aimed at near-term implementation or commercialization
- Collaborative projects led by a receptor and a researcher
Documents Needed
- Intake form
- Guidelines for Funding
- GAPP Funding Opportunity document
Eligibility
Who is eligible?
- Canadian for-profit enterprises
- Subsidiaries of foreign public corporations incorporated in Canada with control exercised in Canada
Who is not eligible
This grant does not explicitly exclude specific types or statuses of companies from applying. Therefore, restrictions related to industry or company type are not specified within the available information.
Eligible expenses
- Individual equipment items up to $100,000
- Services from others, up to 25% of the total budget
- IP protection costs for small businesses, within the allowed limit
Ineligible Costs and Activities
- Market research
- Commercial launches of already-developed technology
- Patent enforcement or litigation
- Projects or services normally funded solely by the receptor
Eligible geographic areas
- Canada
Processing and Agreement
- Applications are reviewed in three stages: letter of intent, full proposal, and pitch.
- LOIs are screened for eligibility before advancing.
- Full proposals are reviewed by external experts and the Core Evaluation Team.
- Advancing teams are invited to pitch to the Core Evaluation Team.
- Funding decisions are recommended by the Core Evaluation Team and approved by Genome Canada.
Additional information
- GAPP funding is conditional on a legally binding intellectual property agreement between project partners.
- Applicants must provide a Data Release and Resource Sharing Plan as part of the full application.
- Regular progress reports are generally required on a semi-annual basis.
- All documentation and follow-up go through a regional Genome Centre.
Frequently Asked Questions about the Genomic Applications Partnership Program (GAPP) Program
Here are answers to the most common questions about the Genomic Applications Partnership Program (GAPP). This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.
What is the Genomic Applications Partnership Program (GAPP)?
The Genomic Applications Partnership Program (GAPP) by Genome Canada provides funding up to $6 million for downstream R&D projects that apply genomics-derived or enabling technologies to real-world challenges identified by Receptor organizations, with a focus on late-stage R&D for near-term commercialization or implementation. Eligible activities must involve active collaboration between an academic researcher and a Receptor organization to generate significant socio-economic benefits in Canada.
How much funding can be received?
Genomic Applications Partnership Program (GAPP) Funds up to 1% of admissible expenses, capped at $6,000,000 per project.
Who is eligible for the Genomic Applications Partnership Program (GAPP) program?
To be eligible for the Genomic Applications Partnership Program (GAPP) program, you must:
Canadian for-profit enterprise
Partnership with a researcher
Independent decision-making required
What expenses are eligible under Genomic Applications Partnership Program (GAPP)?
Development and application of genomics-derived or genomics-enabling tools, products, or processes
Late-stage R&D projects aimed at near-term implementation or commercialization
Collaborative projects led by a receptor and a researcher
Where is the Genomic Applications Partnership Program (GAPP) available?
The Genomic Applications Partnership Program (GAPP) program is available the province of Ontario.
Is the Genomic Applications Partnership Program (GAPP) a grant, loan, or tax credit?
Genomic Applications Partnership Program (GAPP) is a Grant and Funding
Who are the financial supporters of the Genomic Applications Partnership Program (GAPP)?
Genomic Applications Partnership Program (GAPP) is funded by Ontario Genomics, Genome Canada